Amicus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2004
Revenue	423.49	399.36	329.23	305.51	260.89	182.24	Upgrade
Revenue Growth (YoY)	25.74%	21.30%	7.76%	17.11%	43.16%	99.72%	Upgrade
Cost of Revenue	43.95	37.33	38.6	34.47	31.04	21.96	Upgrade
Gross Profit	379.54	362.03	290.63	271.05	229.84	160.27	Upgrade
Selling, General & Admin	289.34	275.27	213.04	192.71	156.41	169.86	Upgrade
Research & Development	139.21	152.38	276.68	272.05	308.44	286.38	Upgrade
Other Operating Expenses	20.92	9.01	11.96	6.21	8.85	4.78	Upgrade
Operating Expenses	449.47	436.66	501.68	470.97	473.7	461.01	Upgrade
Operating Income	-69.93	-74.63	-211.04	-199.92	-243.85	-300.74	Upgrade
Interest Expense / Income	50.74	50.15	37.12	32.47	22.43	18.87	Upgrade
Other Expense / Income	19.79	25.32	-6.12	9.16	7.98	36.3	Upgrade
Pretax Income	-140.47	-150.1	-242.04	-241.55	-274.25	-355.91	Upgrade
Income Tax	6.61	1.48	-5.47	8.91	2.6	0.48	Upgrade
Net Income	-147.07	-151.58	-236.57	-250.46	-276.85	-356.39	Upgrade
Shares Outstanding (Basic)	303	295	289	271	259	240	Upgrade
Shares Outstanding (Diluted)	303	295	289	271	259	240	Upgrade
Shares Change	3.97%	2.11%	6.50%	4.85%	7.67%	29.40%	Upgrade
EPS (Basic)	-0.49	-0.51	-0.82	-0.92	-1.07	-1.48	Upgrade
EPS (Diluted)	-0.49	-0.51	-0.82	-0.92	-1.07	-1.48	Upgrade
Free Cash Flow	-88.03	-76.53	-166.93	-206.38	-236.52	-270.43	Upgrade
Free Cash Flow Per Share	-0.29	-0.26	-0.58	-0.76	-0.91	-1.13	Upgrade
Gross Margin	89.62%	90.65%	88.28%	88.72%	88.10%	87.95%	Upgrade
Operating Margin	-16.51%	-18.69%	-64.10%	-65.44%	-93.47%	-165.03%	Upgrade
Profit Margin	-34.73%	-37.96%	-71.85%	-81.98%	-106.12%	-195.56%	Upgrade
Free Cash Flow Margin	-20.79%	-19.16%	-50.70%	-67.55%	-90.66%	-148.39%	Upgrade
EBITDA	-80.95	-92.08	-199.58	-202.87	-242.98	-332.26	Upgrade
EBITDA Margin	-19.12%	-23.06%	-60.62%	-66.40%	-93.14%	-182.32%	Upgrade
Depreciation & Amortization	8.77	7.87	5.34	6.21	8.85	4.78	Upgrade
EBIT	-89.72	-99.95	-204.92	-209.08	-251.83	-337.04	Upgrade
EBIT Margin	-21.19%	-25.03%	-62.24%	-68.44%	-96.53%	-184.94%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).